AT&T Stadium Getting New Restaurant Coyotes Identify Unnamed Site For New Arena What Brexit Means For EPL, Ryder Cup WADA Suspends Rio Drug Lab Omaha Again Hosts U.S. Swim Trials Devils Offer Facebook Live Coverage Of NHL Draft Gambling Regulators Approve New DFS Platform Tax Return Shows NCAA's Highest Paid Execs Green Sports' Hershkowitz Resigns As President Panel Wants To Reduce Funding For Vegas Stadium
SBD/9/Sponsorships Advertising Marketing
BREATHE RIGHT CRUISES THROUGH FDA APPROVAL TO ADVERTISE
Published November 9, 1995
The FDA said Wednesday that CNS Inc. can advertise Breathe Right to chronic snorers, following an announcement Monday the company's patent application should be approved "within weeks," according to USA TODAY. Although CNS received FDA approval to sell the strips in '93, the company has been forbidden to advertise them. Del Jones of USA TODAY notes "most people know of" the product from watching football. CNS revenue grew from $2.8M in '94 to $36.5M in the first nine months of this year, but CEO Dan Cohen says the product "isn't a fad." He points out that only 10% of the strips are sold to athletes (USA TODAY, 11/9).